Compiling descriptions, results, and analyses from 24 complete or
soon-to-be-complete influential clinical trials studying the efficacy of
pharmacological therapy in hypertension, this detailed reference examines
treatment for hypertension from a variety of perspectives, including trials
sponsored by both international governments and pharmaceutical firms.
Organized to facilitate convenient comparison and evaluation of results for
therapeutic decisions, Clinical Trials in Hypertension
identifies objectives, inclusion/exclusion criteria, baseline characteristics of
subjects, and drug regimens
spotlights trials that established the effectiveness of breakthrough treatments
such as treating young hypertensives with diastolic blood pressure elevations
reviews numerous drug studies-including Heart Attack Primary Prevention in
Hypertension (HAPPHY), Metoprolol Atherosclerosis Prevention in Hypertensives
(MAPHY), and Treatment of